← Back to Search

Dietary Supplement

TrimROX for Weight Management (VNI Trial)

N/A
Waitlist Available
Research Sponsored by Victory Nutrition International, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days of treatment
Awards & highlights

VNI Trial Summary

This trial is testing a new supplement, TrimROX, to see if it helps with weight loss. 100 people will take the supplement for 90 days and be monitored for changes in weight, anthropometric measures, and overall health.

Who is the study for?
This trial is for men and women aged 30-70 who are in good health as determined by their physician. They must understand the study's risks and benefits, agree to consent forms, and not have liver or kidney issues, diabetes with high blood sugar levels, severe heart disease or hypertension, a history of cancer or certain blood disorders. They should not have taken weight management supplements recently.Check my eligibility
What is being tested?
The TRCAP21 study tests TrimROX™'s effect on body measurements like chest, arms, waist/hips/thighs size; mood; energy; hunger; cravings; sleep quality; overall health over 90 days. It also monitors oxygen saturation and blood chemistry to assess changes in physical well-being due to this nutraceutical technology.See study design
What are the potential side effects?
Possible side effects include reactions related to the supplement ingredients which could affect organ functions such as liver or kidneys based on individual sensitivities. Monitoring will identify any adverse events throughout the trial.

VNI Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days of treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days of treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Anthropometric Measurement of the Chest (in Inches)
Anthropometric Measurement of the Hip (in Inches)
Anthropometric Measurement of the Thighs (in Inches)
+5 more
Secondary outcome measures
Pulse Rate Measurement (in beats per minute; bpm)
Saturation of Oxygen in Red Blood Cells (Pulse Ox Measurements; SpO2%)
Systolic and Diastolic Blood Pressure Measurements (in mmHg)

VNI Trial Design

4Treatment groups
Active Control
Placebo Group
Group I: TRCAP21 Group #1 (6.75 gms Once-A-Day)Active Control6 Interventions
TRCAP21 Group #1 (1 Dose; 6.75 gms per day): A total of 25 subjects will be given 1 TRCAP21 sachet; To be taken one in the morning in an empty stomach over a period of 90 consecutive days
Group II: TRCAP21 Group #2 (6.75 gms Twice-A-Day)Active Control6 Interventions
TRCAP21 Group #2 (2 Doses; 13.5 gms in two divided doses per day): A total of 25 subjects will be given 2 TRCAP21 sachets; To be taken one in the morning in empty stomach and the other in the afternoon in an empty stomach over a period of 90 consecutive days
Group III: Placebo Group #2 (6.75 gms Twice-A-Day)Placebo Group6 Interventions
Placebo Group #2 (2 Doses; 13.5 gms in two divided doses per day): A total of 25 subjects will be given 2 placebo sachets; To be taken one in the morning in an empty stomach and the other in the afternoon in an empty stomach over a period of 90 consecutive days
Group IV: Placebo Group #1 (6.75 gms Once-A-Day)Placebo Group6 Interventions
Placebo Group #1 (1 Dose; 6.75 gms per day): A total of 25 subjects will be given 1 placebo sachet; To be taken one in the morning in an empty stomach over a period of 90 consecutive days

Find a Location

Who is running the clinical trial?

Victory Nutrition International, Inc.Lead Sponsor
2 Previous Clinical Trials
300 Total Patients Enrolled

Media Library

TrimROXTM (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT05283525 — N/A
Weight Changes Research Study Groups: TRCAP21 Group #1 (6.75 gms Once-A-Day), Placebo Group #2 (6.75 gms Twice-A-Day), TRCAP21 Group #2 (6.75 gms Twice-A-Day), Placebo Group #1 (6.75 gms Once-A-Day)
Weight Changes Clinical Trial 2023: TrimROXTM Highlights & Side Effects. Trial Name: NCT05283525 — N/A
TrimROXTM (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05283525 — N/A
Weight Changes Patient Testimony for trial: Trial Name: NCT05283525 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there currently an opportunity to enlist in this experiment?

"According to clinicaltrials.gov, this trial is still open for enrollment and was first announced on January 23rd 2022 with the last update occuring on March 3nd 2022."

Answered by AI

Does this research endeavor include individuals aged 25 and up?

"As per the conditions of this research, all participants must be at least 30 years old but not older than 70."

Answered by AI

Is there an opportunity to participate in this experiment?

"This research is recruiting up to 100 volunteers, aged between 30 and 70 years old with physical changes in body weight. In addition, potential patients must abide by the following rules: provide written consent, comprehend the associated risks and advantages of participating in this experiment, be male or female (30-70 Y), receive approval from a medical professional."

Answered by AI

How many participants are currently partaking in this investigation?

"Affirmative, the information on clinicaltrials.gov alludes to this medical experiment actively seeking out trial participants. This research was posted online on January 23rd 2022 and edited more recently in March 3rd 20202. The investigation is looking for a total of 100 patients from 1 site only."

Answered by AI

Who else is applying?

What state do they live in?
Pennsylvania
What site did they apply to?
Dr Bruce S. Morrison
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
2

Why did patients apply to this trial?

I have had rapid weight gain after starting Lyrica.
PatientReceived 1 prior treatment
~32 spots leftby Mar 2025